Our focus is on delivering innovative molecular imaging diagnostics and radiotherapeutics for cancer patients in areas of high unmet medical need. Our strategy is driven by science with a commitment to improve outcomes for patients
Patient Information Leaflet
You can access approved Patient Information Leaflets for your selected country by using the drop down box below. Not all materials are relevant or available in each country.
Axumin is subject to additional monitoring. This will allow quick identification of new safety information.
If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in the package leaflet. You can also report side effects directly via the Yellow Card Scheme at https://yellowcard.mhra.gov.uk/. By reporting side effects, you can help provide more information on the safety of this medicine.
If you wish to report possible side effects for the medicines of Blue Earth Diagnostics please send an email to email@example.com.